Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Medical Research Council, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Medical Research Council, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Medical Research Council, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Medical Research Council, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| Medical Research Council, Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| Medical Research Council, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 3 |
| Medical Research Council, Pharmaceuticals &Healthcare, Deal Details | 14 | 34 |
| Partnerships | 14 | 1 |
| MRC Technology Enters into Co-Development Agreement with IPS-CAS | 14 | 1 |
| MRC Technology Partners with University of Lausanne | 15 | 1 |
| MRC Technology Enters into Agreement with Peptinnovate | 16 | 1 |
| MRC Technology Enters into Co-Development Agreement with Proximagen | 17 | 1 |
| AstraZeneca Extends Collaboration with MRC Technology | 18 | 1 |
| MRC Technology Enters into Drug Discovery Agreement with Daiichi Sankyo | 19 | 1 |
| AstraZeneca Enters Into Drug Discovery Agreement With Medical Research Council | 20 | 2 |
| MRC Technology Enters Into Co-Development Agreement With Oxford University | 22 | 1 |
| MRC Technology Enters Into Co-Development Agreement With Boston University | 23 | 1 |
| MRC Technology Enters Into Agreement With EMBL Enterprise Management For Drug Development | 24 | 1 |
| MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences | 25 | 1 |
| MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences | 26 | 1 |
| Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors | 27 | 1 |
| MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University | 28 | 1 |
| MRC Technology Enters Into Second Research Agreement With University of Bristol | 29 | 1 |
| Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology | 30 | 1 |
| MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists | 31 | 1 |
| MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen | 32 | 1 |
| Medical Research Council, Imperial College, King's College and UCL Form Joint Venture | 33 | 1 |
| Imperial College London, King's College London, University College London, Medical Research Council And GSK Form Joint Venture | 34 | 2 |
| AstraZeneca Enters Into Collaboration With MRC Technology | 36 | 1 |
| Medical Research Council Enters Into Co-Development With Pharmidex | 37 | 1 |
| Licensing Agreements | 38 | 1 |
| Georg-August-University Gottingen Enters into Licensing Agreement with MRC Technology | 38 | 1 |
| MBM ScienceBridge, Georg-August-University Gottingen, University Medical Center Gottingen and MRC Technology, Enter into Licensing Agreement | 39 | 2 |
| UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program | 41 | 2 |
| Cambridge Research Biochemicals Enters Into Licensing Agreement With Medical Research Council | 43 | 1 |
| Phosphate Therapeutics Enters Into Licensing Agreement With Medical Research Council For PT20 | 44 | 2 |
| MRC Technology Enters Into License Agreement With Genentech | 46 | 1 |
| Georg-August-Universitat, University of Regensburg Enter Into Licensing Agreement WIth MRC Technology | 47 | 1 |
| Medical Research Council - Key Competitors | 48 | 1 |
| Key Employees | 49 | 1 |
| Locations And Subsidiaries | 50 | 2 |
| Head Office | 50 | 1 |
| Other Locations &Subsidiaries | 50 | 2 |
| Appendix | 52 | 1 |
| Methodology | 52 | 1 |
| About GlobalData | 52 | 1 |
| Contact Us | 52 | 1 |
| Disclaimer | 52 | 1 |